Today’s report reveals the heavy rotation seen in ASX 100 stocks since the “reopening trades” around the time of Pfizer’s vaccine announcement on 9 November, and highlights some of the most attractive metrics for ASX 100 stocks.
We rank ASX 100 stocks on metrics such as the best share price momentum over various time frames, strongest forecast EPS growth, biggest EPS upgrades, and lowest valuation.